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INTRODUCTION 
Hypoglycaemia is a lab finding which is defined as low levels of 
plasma glucose which may or may not be related to significant pathology.  
Hypoglycaemia that is pathological is caused by large spectrum of 
clinical disorders. 
Several studies have revealed that hypoglycaemia is an 
independent risk factor for mortality and morbidity in hospitalised 
patients. 
Glucose is the major metabolic substrate for brain under 
physiologic conditions. Brain can neither synthesize glucose nor store 
glucose supply of more than few minutes. Hence, it needs continuous 
supply of glucose from systemic circulation. 
Traditionally hypoglycaemia has been linked to diabetes as a 
therapeutic adverse effect. Contrary to popular belief that hypoglycaemia 
occurs mainly in diabetic patients due to OHA/Insulin-food mismatch, 
several studies have shown that hypoglycaemia is common in non 
diabetic patients also. Even in diabetic patients several risk factors 
predispose the individual to hypoglycaemia. 
Glucose is a major fuel source for body tissues and euglycaemia 
between 70 to 140 mg is maintained between insulin and glucagon from 
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pancreas and efficient endogenous Hepatic production of glucose by 
glycogenolysis and neoglucogenesis. When blood sugar level starts 
falling, body tries to maintain homeostasis by suppressing insulin 
secretion as first step followed by stimulating counter hormone response, 
decreasing peripheral glucose uptake and promoting lipolysis and 
ketogenesis. Any derangement in this homeostasis can lead to 
hypoglycaemia. 
Spontaneous hypoglycaemia is a manifestation of disease process 
and reflects derangement in glucose homeostasis. It usually presents as 
sub acute neuroglucopenia. It is essential to recognise different disease 
process that can precipitate hypoglycaemia in patients and prevent their 
recurrence. 
In our hospital we have patients with different diseases but 
admitted with hypoglycaemia. This study is aimed to analyse the disease 
processes and risk factors for hypoglycaemia and to assess whether 
hypoglycaemia is a predictor of in hospital mortality. 
 
 
 
 
  
 
AIMS  
AND  
OBJECTIVES 
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AIMS AND OBJECTIVES 
AIM OF THE STUDY: 
 To identify the clinical pattern of hospitalized patient with at 
least one episode of documented hypoglycaemia 
 
OBJECTIVE OF THE STUDY: 
 To find and analyse the risk factors associated with 
hypoglycaemia 
 
 To determine the incidence of hypoglycaemia in patients 
admitted to medical ward 
 
 To identify if hypoglycaemia with associated risk factors 
predicts increased mortality rate in hospitalized patient 
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REVIEW OF THE LITERATURE 
BLOOD GLUCOSE REGULATION 
Circulating plasma glucose concentration is maintained at a 
constant range since glucose oxidation is a primary source of energy for 
central nervous system. The total body glucose is present in extracellular 
fluid and hepatocytes. This forms the body glucose pool. The glucose 
pool in man is fifteen to twenty (15 to 20 grams) and turnover of glucose 
is 120 to 180 mg/min. It corresponds to 170 to 260 grams/day(1).  t1/2 of 
fasting blood glucose is 60 to 80 minutes. Turnover of glucose decreases 
during fasting and increases during fed state.   Lack of adequate supply of 
glucose results in neuroglucopenia and irreversible damage to brain if 
hypoglycaemia is prolonged. Death may also occur. Glucose 
requirements of brain of healthy people are about one mg/kg/min.It 
corresponds to 100 grams of glucose per day.  
Glucose transport in CNS is by GLUT1 AND GLUT3 transporters. 
Both are independent of insulin. However in fasting state brain can utilise 
ketone bodies as energy source. 
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Glucose levels in blood are determined by balance between glucose 
absorption, production and utilisation. In fasting state glucose production 
is based on glycogenolysis and substrate availability for neoglucogenesis. 
Glucose utilisation is based on glucose uptake by peripheral tissues 
mainly adipose tissue and muscle.(2)  
The following mechanisms are responsible for prevention of 
hypoglycaemia. Glucose levels in blood in post absorptive state is 
constant due to inflow of glucose into the pool balances outflow. 
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Glucose outflow: 
The drain on glucose pool is glucose assimilation by tissues. The 
cells that are freely permeable to glucose are brain, kidney, islets of 
pancreas, liver, intestinal mucosa and erythrocytes.  Striated muscles and 
adipose tissue are mainly responsible for post prandial blood glucose 
disposal and GLUT 4 transporters in muscle and adipose tissue are 
strictly insulin dependent. 
Glucose following entry into the cell is incorporated into the 
metabolic pool. Glucose is first converted to glucose6 posphate by 
hexokinase. 
 
Glucose 6 posphate is the starting point for the following pathways : 
1) Glycolysis 
2) Glycogen synthesis 
3) HMP shunt 
4) Production of hexosamine and mucopolysaccharid 
5) Glucoronic acid 
 
 
 
7 
 
 
 
 
 
 
 
 
The pathway which the glucose molecule chooses depends on  
1) Type of tissue 
2) Redox state 
3) Other substrate availability 
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Glucose inflow:  
Fed state  
The source of inflow is starch from food. Starch is hydrolysed into 
maltose and isomaltose and finally to monosaccharides before absorption 
into circulation. Glucose is the monosaccharide that circulates in blood. 
Galactose and fructose undergo high first pass metabolism in liver. 
Glucose after absorption undergoes three changes 
1) converted to glycogen 
2) converted to fat and others 
3) oxidised to provide energy. 
Fasting state 
Though all tissues remove glucose from blood, liver is the only 
organ that is capable of adding glucose back to blood. The kidneys to a 
lesser extent also does this. Three unique properties of liver that makes it 
a pivotal organ in sugar production is as follows: 
1) Glucose is freely permeable between hepatocytes and  ECF 
through GLUT2  
2) Presence of glucose 6 posphatase enzyme that liberates free 
glucose. 
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3) Presence of neoglucogenic enzymes 
Both the processes of glucose uptake and release occurs 
simultaneously in liver. Net result of glucose uptake or release is 
determined by the differential rates of the above said processes.(3) 
Factors determining the processes in liver are : 
1) Insulin concentration in portal vein 
2) concentration of blood glucose 
 In the post absorptive state insulin levels fall resulting in 
reduced glucose uptake by muscle, fat and liver. Following 
suppression of insulin, glycogenolysis, neoglucogenesis and 
lipolysis are free to occur. 
 In the fasting state glycogenolysis provides much of the glucose 
needs in the initial 12 to 24 hours(4). The amount of liver 
glycogen is determined by preceding diet.After overnight fast, 
liver glycogen is 44 grams(15 to 80 grams). In prolonged 
fasting, hepatic glycogen stores are  depleted.36 hours after 
fasting, glycogen stores is four to eight grams(4 to 8 g) and 
further contribution to glucose production by glycogenolysis is 
diminished(5,6). Lipolysis and protein breakdown take place with 
supply of glycerol, free fatty acids and amino acids. Amino 
acids and glycerol are substrates for neoglucogenesis. 
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Neoglucogenesis takes place in liver and kidney. Fatty acids 
released by lipolysis are used as energy source by the skeletal 
muscle. Liver uses fatty acids to produce ketone bodies. Ketone 
bodies are used as source of energy by various tissues. 
Basal glucose production from neoglucogenesis accounts for 41% 
after 12 hours. It increases to 92% following forty hours of prolonged 
fasting. Kidney accounts for 25% of basal glucose production during 
extended fasting. 
Important enzymes involved in neoglucogenesis are : 
 Glucose 6 posphatase 
 Fruct ose 1-6 Bisposphatase 
 Pyruvate carboxylase 
 Posphoenol pyruvate carboxylase. 
These enzymes make liver and kidney bye pass otherwise vital 
irreversible steps of glycolysis. 
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Important substrates for neoglucogenesis are as follows: 
 Lactate                
 Alanine 
 Pyruvate   
 Glycerol 
 Glutamate  
 Other amino acids 
Eating reduces neoglucogenesis while fasting enhances it. 
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In fed state glucose is the major fuel source to the brain. In the post 
absorptive state and in early fasting, hepatic breakdown of glycogen 
occurs and supplies glucose to brain. In prolonged fasting fat break down 
occurs and ketone bodies form main fuel source for brain. 
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DIAGRAM - A 
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DIAGRAM - B 
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COUNTER HORMONE REGULATORY MECHANISM- 
DEFENCE MECHANISM AGAINST HYPOGLYCEMIA 
 
Counter regulatory hormones are released when blood glucose 
levels decrease below thresehold. This threshold has been estimated at 67 
mg/dl(7). 
 
Ventromedial hypothalamus is vital in starting counter hormone 
response(8). Activation of glucose sensitive neurons in ventro medial 
hypothalamus of the brain is one of the main physiological response to 
hypoglycemia. Activation of this region causes : 
 
1. Stimulation of autonomic nervous system 
2. Release of counterhormones(9-14) 
 
Counter hormones belong to two groups 
Rapidly  acting hormones -   Glucagon , Catecholamine 
Slowly acting Hormones  -    Growth hormone , Cortisol. 
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Secretion of insulin is suppressed at glucose levels of 80-75  mg/dl. 
Counter hormones are released at glycaemic levels of 70 to 65 mg/dl. 
Thus, the first defence mechanism against hypoglycaemia is 
suppression of endogenous insulin secretion.  
 
Glucagon is the second defence mechanism against 
hypoglycaemia and the first counter regulatory hormone to rise. The 
primary action of glucagon is increase in glucose production by liver by 
stimulating glycogenolysis and neoglucogenesis. It has little effect on 
peripheral utilisation of glucose and glucose production by kidneys. 
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Though glucagon stimulates lipolysis and ketogenesis,it has minimal net 
effect on mobilisation of neoglucogenic precursors from adipose tissue. 
Catecholamines have several effects on glucose homeostasis. It causes  
 Suppression of insulin secretion 
 Stimulation of neoglucogenesis-Hepatic and renal 
 Stimulation of glycogenolysis 
 Stimulation of lipolysis 
 Stimulation of lipolysis provides glycerol for neoglucogenesis 
and free fatty acids for ketone bodies production. 
The slow acting counter regulatory hormones namely Growth 
hormone and cortisol have a limited role in acute hypoglycaemia. They 
play a significant role in periods of prolonged fasting. Their levels usually 
rise about three hours after fasting. The major glucoregulatory effects of 
these hormones are on hepatic neoglucogenesis and lipolysis. There is 
increased level in production of free fatty acids and glycerol. They also 
peripheral utilisation of glucose is also suppressed. The production of free 
fatty acids and ketone bodies are greatly glucose sparing since they are 
used as alternate fuel by several tissues including skeletal muscles. 
Patients with low fat reserve, who cannot adequately augment lipolysis, 
in period of fasting, are prone for severe hypoglycaemia as they lack 
these alternate fuels. 
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DIAGRAM - A 
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DIAGRAM - B 
 
DEFENCE AGAINST HYPOGLYCEMIA
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Thus, when glucose levels start falling, there is pancreatic switch 
off of  beta cells that automatically inhibits Insulin  secretion. This occurs 
at lower limits of physiological levels of blood glucose. The paracrine 
effect of beta on alpha cells helps to increase glucagon levels. 
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Normally Brain responds to hypoglycaemia. Several regions of 
hypothalamus initiate a stress response to bring back euglycemia. The 
regions of Hypothalamus that are vital in sensing and responding to low 
blood sugar levels are ventromedial hypothalamus, paraventricular 
nucleus and arcuate nucleus. 
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Definition of hypoglycaemia 
The diagnosis of hypoglycaemia is based on Whipple’s triad(15)  
• Symptoms consistent with hypoglycaemia 
• Low blood glucose concentration 
• Relief of symptoms when blood glucose level is raised to 
normal by exogenous administration of glucose 
As per A DA recommendations plasma glucose level below 70 
mg/dl is taken as hypoglycaemia. 
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SIGNS AND SYMPTOMS OF HYPOGLYCAEMIA 
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Hypoglycemic symptoms are due to : 
1.adrenergic  2.cholinergic  3.neuro glucopenic 
 
 
 Cholinergic symptoms are mainly hunger, sweating and 
paresthesia. 
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Mild, moderate and severe hypoglycaemia are based on prevailing 
blood sugar levels and the promptness of counterhormone 
response. 
 
 
 
In mild hypoglycaemia patient has increased hunger, tiredness, 
exhaustion. When sugar levels fall further down patient experiences 
increased sweating, tremors, palpitations. Neuroglycopenic symptoms 
also occur simaultaneously like dizziness, lack of concentration, 
irritability and altered mental behaviour. In severe hypo when blood 
glucose falls below40 mg % the patient presents with altered sensorium, 
seizures leading on to coma and death. 
 
 
  
CLASSIFICATION OF HYPOGLYCAEMIA
 
Pseudo hypoglycaemia is also called relative hypoglycaemia.
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Hypoglycaemia commonly occurs due to drugs taken for treating 
diabetes mellitus in outpatient setup but in case of hospitalised patients 
hypoglycaemia is caused by numerous entities which should be identified 
and treated accordingly. 
The subject of hypoglycaemia in adult hospitalised patient is not 
dealt in detail in many of the textbooks though it is mainly presented in 
the context of diabetes mellitus management. But in reality we come 
across many hypoglycaemic episodes in hospitalised patients not 
suffering from diabetes mellitus. 
The present study is aimed at determining the spectrum of 
disorders and associated risk factors in causing hypoglycaemia in 
hospitalised patient in a tertiary care setup. 
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ADULT HYPOGLYCEMIA - CAUSES 
 
A. Internal causes 
1.INSULIN MEDIATED 
• Reactive hypoglycemia 
• Insulinoma 
• Insulin antibody 
• nesidioblastosis 
 
2. INSULIN INDEPENDENT 
• Congestive cardiac failure 
• Liver disorders 
• Kidney failure 
• Sepsis 
• Endocrine abnormalities 
• Antibody to insulin receptor 
• Neoplasia  
 
 
29 
 
 
 
 
B.External  causes 
1) Medications 
i) Direct effect 
 sulfonylureas 
 insulin 
 pentamidine 
 anti malarials 
 diisopyramide 
 Beta2 adrenoreceptor agonist 
 
Drug interaction  
 Biguanides 
 PPRγ agonists 
 Beta blockers 
 ACE inhibitors 
          2) Ethanol 
          3) Factitious     
4) Toxins 
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Drug induced hypoglycaemia 
Various drugs are found to be associated with hypoglycaemia. But, 
the direct cause effect relationship is not elucidated in many cases. 
Predisposing factors include : 
• Very young age 
• Very old age 
• Impaired liver function 
• Impaired renal function 
• Poor nutrition  
 
Mechanism of drug induced Hypoglycaemia 
 Augmenting insulin release due to stimulation of insulin 
secretion mechanism 
 Direct toxicity to pancreatic islets causing non regulated insulin 
release 
 Increased peripheral uptake of glucose 
 Decreased glucose production by liver 
 Potentiate effects of insulin and sulfonylureas  
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Drugs that increase insulin release:  
1.Quinine 
Quinine and its derivatives cause hyperinsulinemic hypoglycaemia. 
2.Diisopyramide 
Diisopyramide increases insulin secretion from Beta cells of 
pancreas. It closes k+ATP channel of Beta cell, binding to a site different 
from site of sulfonylurea. 
3.Ritordine 
Ritordine therapy to prevent premature labour can cause increased 
insulin secretion. 
4.Pentamidine 
Pentamidine used for treating PCP pneumonia and trypanosomiasis 
and leishmaniasis is toxic to Beta cell of pancreas. 
Drugs that increase insulin sensitivity 
1.Biguanides and PPRγ agonists 
Biguanides and PPRγ agonists usually is not associated with 
hypoglycaemia when consumed alone.But, they increase the risk of 
hypoglycaemia caused by insulin and sulfonylureas by augmenting 
32 
 
 
 
glucose uptake and utilisation.Metformin also reduces hepatic glucose 
production and reduces intestinal glucose absorption. 
2.ACE inhibitors 
ACE inhibitors indirectly augment insulin sensitivity. They 
increase circulating kinins causing vasodilatation and increase glucose 
uptake by muscles. However, they are safe and hypoglycaemic risk is 
low. 
3.Beta blockers 
Beta blockers oppose the catecholamine effect on uptake of 
glucose and lipolysis. They enhance uptake of glucose in skeletal muscle. 
Lipolysis suppression and consequent reduction in NEFA augments 
insulin sensitivity. They indirectly reduce neoglucogenesis. However they 
decrease insulin secretion from Beta cells of pancreas. Hence, insulin 
treated patients are prone for hypoglycaemia and type 2 DM patients are 
prone for hyperglycaemia. Adrenergic response to hypoglycaemia is 
blunted by Beta blockers and thus predisposing patients for 
Hypoglycaemic unawareness. 
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Alcohol 
Hypoglycaemia due to alcohol ingestion occurs in all age groups 
and different classes of society. It is more severe in extremes of age, men, 
malnourished persons. Consuming alcohol accidentally by young children 
may cause hypoglycaemia(16).Alcohol is implicated in 18-56% of people 
admitted due to severe hypoglycaemia(17). 
Mortality rate in hospatilised patient due to alcohol related 
hypoglycaemia is almost 10%(17). 
 The main mechanism of alcohol induced hypoglycaemia is 
inhibition of neoglucogenesis. 
Cytoplasmic enzyme  Alcohol dehydrogenase oxidizes ethanol to 
aldehyde which is a NAD dependent. 
Acetaldehyde is oxidized to acetate by aldehyde dehydrogenase  
that is a mitochondrial enzyme . It also utilises NAD+. 
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There is a shift in redox status of the cell with high NADH/NAD+ 
ratio due to oxidation of ethanol. 
 
Several metabolic changes occur which  have dangerous effects in 
alcoholics. They include : 
 
 LACTIC ACIDOSIS :  
o High level of NADH helps in conversion of pyruvate to 
lactate. 
This leads to accumulation of lactate causing lactic acidosis. 
 HYPOGLYCAEMIA: 
o There  is lack of pyruvate for oxaloacetete production 
along with malfunctioning of malate shuttle depressing 
neoglucogenesis .This causes hypoglycaemia(18). 
 
 KETOGENESIS : 
o TCA cycle slows down due to accumulation of NADH 
causing increased availability of acetyl coA. This causes 
ketogenesis. 
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 FATTY LIVER :  
o Synthesis of fatty acid is favoured but there is deficient 
mobilisation. Lipoproteins are not effectively synthesised. 
This leads to accumulation of fat in the liver. 
 
 Ethanol inhibits gluconeogenesis but not glycogenolysis. 
 
 Ethanol suppresses release of, growth hormone, corticotrophin, 
cortisol. Epinephrine and glucagon responses to severe 
hypoglycaemia are delayed. All these contribute to fasting 
hypoglycaemia(19).  
 
 Alcohol also causes reactive hypoglycaemia. Consumption of 
moderate amount of alcohol increases secretion of insulin 
following glucose stimulation. Person taking alcohol and 
sucrose may experience hypoglycaemia due to excess of 
insulin(20). 
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Clinical characteristics 
Generally patient is an alcoholic with moderate to large 
consumption of alcohol but no carbohydrate or protein intake in previous 
12-24 hours. Patient may be comatose or suffer from seizures. Most of 
the patients do not have adrenergic responses to low blood sugar levels 
and directly result in neuroglucopenia. 
 
INTERNAL CAUSES OF HYPOGLYCAEMIA 
Hospitalised patients with organ failure are more prone for 
hypoglycaemia. 
 
CARDIAC FAILURE 
Hypoglycaemia occurs in people with severe congestive cardiac 
failure. causes may be due to cachexia and Liver dysfunction due to 
congestion and hypoxia and lack of substrates for gluconeogenesis 
Patients with severe heart failure in icu may develop ischemic 
hepatitis and hypoglycaemia(21-23). 
Several studies have shown that hypoglycaemia is common in 
cardiac failure secondary to coronary heart disease, RHD, 
Cardiomyopathy and even COPD. 
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Reasons thought are low calorie intake, malabsorption, increase 
utilization of glucose by cardiac tissues that are ischemic. Hepatic 
congestion and liver dysfunction are also discussed as one of the 
mechanisms. Studies recommend checking of blood sugar in people with 
congestive cardiac failure presenting with altered sensorium or 
confusion(24). 
 
RENAL FAILURE 
End stage kidney disease is associated with hypoglycemia(25).The 
common pathologies associated are  
 Drug induced 
 Malnutrition  
 Sepsis 
There is also high rate of mortality. Haemodialysis can cause 
spontaneous hypoglycaemia in both diabetic and non diabetic patients 
during or after dialysis(26). 
Response to hypoglycaemia is blunted and unawareness is 
commonly seen(27).The pathogenesis includes the following 
• decreased  gluconeogenic substrates In patients with severe 
cachexia, low carbohydrate intake and malnutrition. 
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• increased circulating levels of insulin due to decreased 
clearance  
• increased resistance to glucagon 
•
 suppression of renal gluconeogenesis(28,29) 
Kidney glucose production and output accounts for 25% of serum 
blood glucose level in post absorbtive states in normal people. It increases 
to 40% during hypoglycemic states in healthy individuals. As this is 
hampered in chronic renal disease, these people are prone for 
hypoglycaemia(29,30) 
 
LIVER DISORDERS 
As we have already seen,  neoglucogenesis and glycogenolysis are 
important for maintaining the post absorptive glucose state.Both the 
processes occur almost exclusively in the liver and hence hypoglycaemia 
occurs in liver dysfunction. 
Hypoglycaemia occurs in severe hepatic failure due to fulminant 
viral, toxic hepatitis. It is also common in alcoholic hepatitis and fatty 
liver. Hypoglycaemia occurs in last stages of cirrhosis with liver cell 
failure(31). 
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SEPSIS 
In hospitalized patients hypoglycaemia is commonly seen in sepsis. 
There are generally two metabolically different phases associated with 
sepsis. In its early phase there is hyperglycaemia and this is followed by 
phase of hypoglycaemia in which there is reduction in glucose output in 
liver. There is 
 
• Rapid depletion of glycogen content in liver 
• Impaired glycogenolysis 
• Depressed neoglucogenesis 
•
 Enhanced peripheral utilization of glucose(32) 
 
There is alteration in transcriptional regulation of beta 2 adrenergic 
receptor gene expression. This is responsible for altered glucose 
metabolism in liver in sepsis(33). 
 
There is increased utilisation of glucose by macrophage rich tissues 
like spleen, liver and lung.This causes increased utilization(34). 
 
Muscle and fat cells make less contribution to the enhanced 
glucose utilization. Cytokines produce insulin resistance and also increase 
insulin secretion. The imbalance between glucose utilization and glucose 
production contribute to prevailing glycaemic status(35,36). 
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In cases of endotoxemic shock, in experimental animals, 
hypoglycaemia has been documented due to inhibition of 
neoglucogenesis(37). 
 
 
Hypoglycaemia in sepsis and mortality: 
Several studies have revealed that overwhelming sepsis is 
associated hypoglycaemia, which indicates grave prognosis. The risk of 
hypoglycaemia in sepsis increases with prolonged starvation, malnutrition 
and presence of organ failures(38). 
 
One study showed that about 8.6% of patients with severe 
pneumococcal sepsis had episodes of  hypoglycaemia that correlated with 
increased mortality. Hence, the study recommends frequent  blood sugar 
measurements  even in non diabetic patients with sepsis to avoid 
deleterious effects of hypoglycaemia(39). 
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Endocrine Deficiencies : 
  
          Deficiency of glucagon is generally rare in clinical practice. 
Similarly deficiency of epinephrine alone rarely  ever causes 
hypoglycemia in the absence of hyperinsulism. 
 
 Patients with hypopituitarism can have low blood sugar when 
glucose utilization is enhanced as  during exercise. In patients 
with primary adrenal insufficiency fasting glucose levels are 
usually normal(40). 
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CAUSE OF HYPOGLYCEMIA 
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Immune hypoglycemia : 
Due to:  
 antibodies against insulin 
 antibodies against insulin receptor 
 Insulin antibodies 
 
Predisposition 
 Japanese 
 New onset type I DM 
 Autoimmune diseases 
 Relatives of type I DM  
 Patient taking insulin injection 
 Medications having –SH group 
 
 Post insulin injection/Post meals leads to large amount of insulin in 
blood which is mainly bound to antibodies. This leads to hyperglycaemia 
followed few hours later in the release of bound insulin leading to late 
hypoglycaemia. 
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Remedial measures to be taken are 
 Avoid inciting drugs 
 Frequent low carbohydrate diet 
 Drugs which delays glucose absorption 
 Insulin receptor antibodies 
 
Predisposing causes 
i) Women 
ii) Autoimmune disorders 
iii) Hodgkin’s lymphoma 
          
 Antibodies are of polyclonal origin with multiple sub classes of 
immunoglobulins. Some Ig stimulates the insulin receptor while others 
inhibit it. Titer of these subclasses of immunoglobulin varies at various 
point of time. This leads to the occurrence of hyperglycaemia and 
hypoglycaemia at varied intervals in the same patient(41). 
 
Lab findings 
i) Hypoglycaemia and hyperglycaemia 
ii) Insulin receptor antibodies in varying titer 
iii) Low C peptide levels 
iv) High insulin levels 
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Postulated mechanisms 
1) Diminished clearance of circulating insulin 
2) Stimulation of pancreatic beta cells receptor by antibodies. 
 
Management 
 Plasmapheresis 
 Cytotoxic drugs 
 
Poor prognosis due to : 
 Severe hypoglycaemia 
 Associated malignancy 
 Associated auto immune diseases 
 
Reactive hypoglycaemia 
          It is a direct but delayed consequence to a rise in blood sugar 
following glucose load. It may be symptomatic or asymptomatic. 
 
Mechanism 
 Ingestion of oral glucose is followed by rise in blood sugar 
concentrations. Peak is reached in thirty to sixty minutes. This time also 
corresponds to peripheral uptake of glucose maximally. Generally 
glucose levels start falling after this time. However, second and third 
peaks of glucose and insulin levels have been documented(42,43,44). 
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 Concentration of blood glucose falls at a rate that is slower and 
with considerable variations than the rise. Generally, plasma 
glucose levels reach nadir three to five hours following 
ingestion of glucose drink(43,45). 
  
 The size of oral glucose load ,presence of other nutrients and the 
rate of gastric emptying determine the time of glucose nadir. Following 
ingestion of one hundred grams of glucose, it takes two hundred and forty 
minutes(four hours) to achieve this nadir(43,45).  However, it may occur 
between one hundred and twenty to three hundred and sixty minutes. (2 
to 6 hours). The nadir is below the fasting blood sugar levels. 
 
 Larger quantity of glucose used for loading test result in occurrence 
of reactive hypoglycaemia more frequently. Consuming large quantity 
during loading test leads to prolonged duration of hyperglycaemia. But, 
the peak value is not increased to the same extent(46-50).It is followed by 
hypoglycaemia. 
 
 
Mechanism postulated for above phenomenon are 
1) Absorption of glucose is rate limited 
2) Increased insulin secretion on account of  large glucose load and 
stimulation by other enteric hormones. 
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          Reactive hypoglycaemia represents short period in 
absorptive and post absorptive phase, when glucose uptake by 
peripheral tissues and the liver exceeds glucose input from both 
GIT and liver. It occurs due to : 
 
• Continuous glucose uptake by skeletal muscle and adipose tissue 
following preceding hyperinsulinemia. 
 
• Enhanced tissue sensitivity, eventhough the insulin levels are 
returned to baseline. 
 
• Input from GIT stops abruptly during a brief period when liver is 
predominantly in the process of glycogen storage. 
 
The severity of reactive hypoglycaemia is increased by : 
 Intake of very large glucose loads and insulinotropic 
carbohydrates which include galactose, maltose, sucrose  but 
not fructose. 
 
 Ingestion of carbohydrate with alcohol  
 
 Ingestion of sugars following carbohydrate deprivation(51-53).  
 
          The rate of gastric emptying plays a major role in reactive 
hypoglycaemia. 
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Types of  reactive hypoglycemia       : 
 i) Alimentary 
 ii) Early diabetes 
 iii) Idiopathic 
 
Alimentary: 
 Occurs after gastrectomy surgery(54) due to rapid transit of food in 
the GIT leading to fast absorption of glucose which in turn stimulates 
insulin secretion. The effect of secreted insulin lasts long leading to 
hypoglycaemia. 
 
Early diabetes: 
 Reactive hypoglycaemia is considered to be a harbinger of early 
Diabetes Mellitus in the person(55). This manifestation, however, is not 
seen frequently in Diabetes mellitus. Post meals, these people have 
minimal hyperglycaemia and hypoglycaemia after 3 to 5 hours. 
 
Idiopathic 
 Autonomic symptoms occurring after meals in few individuals fall 
under this category. Many a times the blood sugar measured during the 
period of symptoms were found to be normal. 
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HYPOGLYCEMIC EPISODES  IN DIABETES :  
 
 Hypoglycemic episodes are significant limiting factor in the 
treatment of  Diabetes(56,57). it causes severe morbidity in patients with  
 
 T1DM  and in advanced T2DM.  
 
 Hypoglycemia may sometimes prove fatal in diabetes. Several 
papers have reported  death in bed where hypoglycemia has 
been cited as an important risk factor(58,59). It can cause death 
due to cerebral damage also(60). 
 
 Hypoglycemia in both T1DM and T2DM are the net result of : 
 
1.therapeuic hyperinsulinemia that is absolute or relative 
 
2.reduced defence mechanisms against hypoglycemia(61,62).  
 
 Hypoglycemia is more common in T1DM patients with 
absolute insulin deficiency than T2DM patients with OHA . 
however incidence of hypoglycemia in patients with advanced 
long standing duration of T2DM   is also increased. 
 
 Hypoglycemia in diabetics is a complex process. It is not a mere 
therapeutic side effect. The endogenous defense mechanism 
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against hypoglycemia are blunted starting early in T1DM and in 
advanced T2DM.The impairment of  defense mechanism is 
profound in long standing T1DM patients and mild in T2DM 
patients. 
 
Hypoglycemia in T1DM :  
 In T1DM mechanism of hypoglycaemia is very complex because it 
is due to: 
 
 Complete exogenous administration of insulin 
 
 The first defence mechanism  to hypoglycaemia of inhibiting 
endogenous insulin secretion from beta cells is not there. Hence, 
sugar level drops down. 
 
 The response of glucagon to low blood sugar levels begins to 
fail within two years of  T1DM and after five years, an impaired 
response is universal(63).This is  because of  disruption in the 
paracrine effect of  beta cells on alpha cells as endogenous 
insulin production is negligible. 
 
 There is also decreased sympathoadrenal responses to 
hypoglycaemia in long standing diabetes(64). 
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 The above mechanisms make T1DM patient more sucesptible to 
severe and fatal hypoglycaemic episodes.Recent reports reveal 
that 6 to10% of patients with T1DM die of hypoglycaemia(65). 
 
 
Hypoglycaemia in T2DM 
 
 Hypoglycaemia in type 2 diabetes occurs due to the following 
reasons. 
 
 Long acting sulfonylureas  
 Missing if meals/delayed meals. 
 Insulin/OHA-  food mismatch 
 Sternuous/unaccustomed exercise 
 Elderly patients 
 Gastroparesis 
 Drugs that either enhance sulfonylurea action or improve 
insulin sensitivity 
 Organ failure 
 Endocrine disturbance like hypopituitarism, hypothyroidism 
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Hypoglycaemia associated autonomic failure 
 
 HAAF is functional disorder of dynamic nature which is 
associated with defective glucose counter regulation and 
hypoglycaemia unawareness. Dysregulated counter hormone 
response includes failure of inhibition of insulin secretion and 
failure of increase in glucagon secretion following 
hypoglycaemia.  
 
 This is accompanied by reduction of epinephrine responses to 
further episodes of hypoglycaemia. The reduced sympatho -
adrenal  responses results in attenuation of symptoms. 
 
Three main predisposing factors are  
 Nocturnal hypoglycaemia 
 Prior exercise  
 Antecedent hypoglycaemia(66-69).  
 
HAFF is more characteristic of T2DM than T1DM. 
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HYPOGLYCEMIA AND BRAIN 
 Activation of glucose sensitive neurons in ventro medial 
hypothalamus of the brain is one of the main physiological response to  
acute hypoglycemia.  Activation of this region causes : 
 1. Stimulation of autonomic nervous system 
 2. Release of counterhormones(70)  
 In patients with severe and profound hypoglycemia hypoglycaemic 
encephalopathy occurs. 
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  MRI Bran in patients with hypoglycaemic encephalopathy 
reveals increased vulnerability of basal ganglia, substantia nigra, 
cerebral cortex and hippocampal regions . The lesions are usually non 
haemorragic(71). 
 
 Repeated hypoglycaemic episodes may lead to cognitive 
impairement due to neuronal cell death in the hippocampus(72).  
 
 
 
 
 Diffusion restricted MRI in a patient with hypoglyemic coma 
reveals diffusion restriction in bilateral internal capsules along the 
post. Limb and splenium of corpus callosum. 
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HYPOGLYCEMIA AND HEART 
  Hypoglycaemia produces significant prolongation of QT c 
interval. Increased levels of catecholamines during hypoglycaemic 
episodes may be responsible for QTc lengthening leading onto 
ventricular arrhythmias and sudden cardiac death.They may also lead 
to hypokalemia that may cause cardiac repolarisation 
abnormalities(73,74,75).  
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  Hypoglycaemic episodes are associated with the relase of 
inflammatory cytokines which include IL-8,IL-6,CRP,TNFα and 
endothelin-1.These cytokines produce injury to endothelium and cause 
coagulation abnormalities.Stiffness of vessel wall increases during 
hypoglycaemia. Thus, endothelial dysfunction and inflammation can 
potentiate cardiovascular risk in hypoglycaemia(75,76,77) 
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APPROACH TO HYPOGLYCEMIA 
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MANAGEMENT OF HYPOGLYCEMIA 
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MATERIALS AND METHODS 
Study Population:  
 All patients admitted in medical ward with  hypoglycemia  in 
Madras Medical College and Rajiv Gandhi Government General 
Hospital, Chennai. 
Inclusion Criteria:  
1. Patients admitted in medical ward who have at least one episode of 
documented hypoglycaemia i.e less than 70mg/dl. 
2. Age > =18 years 
Exclusion Criteria:  
     1. Pregnant woman 
     2. Paients less than 18 years of age 
     3. Patients not willing to participate in the study 
Study Centre:  
 Institute of Internal Medicine, Madras Medical College and Rajiv 
Gandhi Government General Hospital, Chennai. 
Study Design: 
 Prospective, Observational study 
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Sample Size:  
 119 cases 
Duration of the study: 
6 months :  April 2015-September 2015. 
Ethical committee approval :  
 Ethical committee approval was obtained from institution ethical 
committee before starting the study. 
Data collection and Methods: 
Patients who present with symptoms of hypoglycemia at the time 
of admission or during the hospital stay are taken up for the study. 
Symptoms of hypoglycemia may vary from mild to severe. 
Patient presenting with sudden onset of seizure, altered behavior or 
altered sensorium either in the emergency department or in the medical 
wards  are checked immediately for blood sugar with capillary blood 
glucose measurement.  Any documented blood sugar value less than 70 
mg/dl is taken as hypoglycaemia and the patient is taken up for study 
after obtaining consent from the patient or the relatives ,if the patient is in 
altered sensorium. Even those patients whose routine blood sugar shows 
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hypoglycaemia (<70 mg/dl) are included in the study, even if they are 
asymptomatic. 
Only pregnant patients and patients less than 18 years of age are 
excluded from the study. Detailed informed consent is obtained from the 
patient or from his close relatives, if the patient is in altered sensorium. 
All patients who qualify for the study and had given consent are 
evaluated by means of a questionnaire which contains details of  
1. Clinical history which includes includes relevant symptoms 
2. Detailed past medical history that includes the presence or 
absence of diabetes, duration of diabetes and other known clinical illness 
like RHD,CAD, CKD,  DCLD, Pulmonary Tuberculosis, Bronchial 
Asthma, Seizure disorder etc. 
3. Personal habits which include diet sleep pattern, 
Alcohol/tobacco/cannabis/ cocaine and other drug abuse. 
4. Previous drug and treatment including insulin injection,oral 
hypoglycaemic drugs and other medications. 
5. History of recent poisoning, native drug abuse, tattooing, blood 
transfusion. 
6. Sexual behavior and promiscuity  
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7. Detailed Physical examination 
 General examination including vital signs 
 Anthropometry 
 Cardio vascular system 
 Respiratory system 
 Abdomen 
 Central nervous system 
 
8. Laboratory investigations  
 Complete Blood Count, ESR 
 CRP 
 Urine routine 
 Renal function test 
 Liver function test 
 Serum Electrolytes 
 Thyroid function test 
 Urine culture and sensitivity 
 Blood culture and sensitivity. 
 Electrocardiogram 
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9. Relavent imaging 
 Chest Xray 
 Ultrasonogram abdomen 
 CT scan Brain 
 MRI Brain 
Data thus collected was subjected to detailed statistical analysis 
including chi square test. 
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OBSERVATION AND RESULTS  
 In the six months study period around 119 patients admitted in 
medical wards of Madras medical college hospital were found to have 
atleast one episode of documented hypoglycaemia. Patients were further 
investigated and data obtained analysed statistically. 
The primary diagnoses of the patients are as follows: 
• Diabetes with Chronic kidney disease  : 45 (37.81%) 
• Chronic kidney disease      : 17 (14.28%) 
• Acute liver dysfunction    : 17 (14.28%) 
• Chronic liver disease    : 4 (3.36%) 
• Sepsis      : 10 (8.4%) 
• Congestive cardiac failure  : 11 (9.24%) 
• Alcohol intoxication   : 3  (2.52%) 
• Malignancy     : 3  (2.52%) 
• Chronic Pancreatitis   : 3  (2.52%) 
• Diabetes Therapy related   : 5  (4.20%) 
• Reactive      : 1  (0.84%) 
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 The aim of the study is to analyse the clinical pattern of patients 
admitted with hypoglycaemia. This is done by analyzing the 
• Primary Diagnosis 
• Sex pattern 
• Age pattern 
 
 
 
 Diabetes with Chronic Kidney Disease was found to be the most 
common primary diagnosis .There were totally 45 patients in this 
category which accounts for 37.81%. Non Diabetic CKD and Acute Liver 
Dysfunction account for 14.28% each. Sepsis and Congestive cardiac 
failure Constituted 8.4% and 9.24% respectively. Contrary to the popular 
belief, Diabetes therapy related cases account for 4.2% only. 
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Sex distribution of the study sample 
 
 
 
 
 
 
 
 
 In the present study male population accounted for 75.63% and 
females accounted for 24.36%.Thus in the present study male gender 
constituted for significant 3/4th of the study sample. 
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Age distribution of the study sample 
 
 
 
 
 
 
 
 
 
In the present study patients in the age group of 41 to 60 years 
accounted for 54.6% followed by 61 to 80 years age group which 
constituted 34.5%. 
 
2
11
65
41
0
10
20
30
40
50
60
70
0-20 yrs 21-40 yrs 41-60 yrs >60 yrs
frequency
frequency
Age Frequency Percentage 
0-20 2 1.7 
21-40 11 9.2 
41-60 65 54.6 
61-80 41 34.5 
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INCIDENCE OF HYPOGLYCAEMIA DURING  
THE STUDY PERIOD 
 
Total number patients with documented hypoglycaemia  is 119.                        
Total number of Patients admitted in medical wards during the 
period   11276   
Incidence of hypoglycemia in the present study is about 1.05%. 
Incidence of hypoglycaemia was calculated by taking into account the 
patients admitted in medical wards alone during the study period . 
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Hypoglycaemia in diabetic patients 
 
 
 
 
 
 
0
5
10
15
20
25
30
35
40
45
50
DIABETES MELLITUS
DIABETES MELLITUS
72 
 
 
 
 
 
DM ASSOCIATION FREQUENCY 
PERCENTAGE  
(%) 
CKD 45 67.1 
SEPSIS 5 7.46 
THERAPY RELATED 5 7.46 
CCF 5 7.46 
ALD 3 4.47 
CH.PANCREATITIS 3 4.47 
CLD 1 1.49 
TOTAL 67 100% 
 
 
In diabetic patients Kidney disease  accounts for major cause of 
hypoglycemia accounting for 67.1%. Therapy related hypoglycemia 
accounts for only 7.46%   in the present study. Sepsis and CCF accounts 
for 7.46% each. 
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Various risk factors frequency 
 
 
 
Risk Factor Frequency Percentage (%) 
Renal Failure 69 57.98 
Diabetes Mellitus 67 56.3 
Alcoholism 59 49.57 
 
In the present study, Chronic Renal Failure and Diabetes Mellitus 
ranks close first and second risk factors associated with occurrence of 
Hypoglycemia in hospitalized patient. Out of 119 patients, 69 patients 
had chronic renal failure and 67 patients had diabetes mellitus. 
Alcoholism was also found in 59 patients. 
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Mortality Pattern in Diabetes Mellitus 
 
 
Chi square table for DM as a predictor of mortality 
Risk factor mortality No mortality total 
Diabetes present 15 52 67 
Diabetes absent 11 41 52 
total 26 93 119 
 
p value significance level   0.05 
Chi Square Value  : 0.0261 
P value   : 0.8716 
As the p value for the given data is greater than 0.05 ,it is not 
significant. Thus, diabetes mellitus, though is common association of 
hypoglycaemia, it is not a predictor of mortality. 
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In the present study, there were 67 patients (56.3%) who had 
diabetes mellitus. Number of deaths among the diabetic patients were 
fifteen (15) while it was twenty six 26 for the whole study sample. Thus, 
diabetes mellitus accounted for 56.3% of cases and57.9% of the cases of 
death. In order to find out if diabetes mellitus is predictor of mortality in 
hospitalized patients having hypoglycaemia, statistical analysis by using 
chi square test was done with significant p value at 0.05. 
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Mortality Pattern of Renal Failure 
 
 
 
 Renal Failure was diagnosed in 69 cases .This form about 57.98% 
of the study sample. Of the 69 cases 15 patients died .This means 21.73% 
of the patient afflicted with Chronic Renal Failure died. This amounts to 
57.69% of the total deaths.(15/26)  
 To know if Renal Failure is a mortality predictor in hypoglycaemic 
patient statistical analysis by utilizing chi square test was carried out. 
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Chi Square Table for Renal Failure as a predictor of Mortality 
 
p value significance level   0.05 
 
Chi Square Value       : 0.0012 
P value          : 0.9728 
 
 As the p value for the given data is greater than 0.05 ,it is not 
significant. Thus, Renal failure, though is common in hospitalized 
hypoglyvaemic patient, it is not a predictor of mortality. 
 
 
  
Risk factor mortality No mortality total 
Renal failure 
present 
15 54 69 
Renal failure 
absent 
11 39 50 
total 26 93 119 
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Mortality Pattern of Congestive Cardiac Failure 
 
 
 
 Of the 119 patients enrolled in the study, Congestive heart Failure 
was present in eleven(11) cases. This is found to be 9.24% of the study 
sample. But, the number of cases who died in this sub class were six i.e 6 
patients. This is approximately 23% of all deaths.Death rate among this 
sub category of patients were 6/11*100 which is 54.54%  
 
A Chi Square test analysis was carried out on the above data to find 
out if the presence of CCF is a significant predictor of mortality. 
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Chi Square Table for CCF as a predictor of Mortality 
 
 
p value significance level   0.05 
Chi Square Value       : 7.5886 
P value          : 0.0058 
 
 As the p value for the given data is lesser(p<0.05) than 0.05 ,it is 
significant. Thus , cardiac failure in hypoglycaemic patient is a significant 
predictor of mortality. 
 
 
 
 
 
 
Risk factor mortality No mortality total 
Heart failure 
present 
6 5 11 
Heart failure 
absent 
20 88 108 
total 26 93 119 
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Mortality Pattern of sepsis 
 
 
 
 Sepsis was diagnosed in ten cases (10 cases).While this amounts to 
just 8.4% of the study sample about 60% of the sepsis diagnosed patient 
that is 6 out of 10 sepsis diagnosed patients succumbed to it. 
 
Statistical analysis by utilizing chi square method with 0.05 
significant p value was done.The result is tabulated as follows 
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Chi Square Table for Sepsis as a predictor of Mortality 
 
Risk factor mortality No mortality total 
sepsis present 6 4 10 
sepsis absent 20 89 109 
total 26 93 119 
 
p value significance level   0.05 
 
Chi Square Value  : 9.3063 
P value   : 0.0022 
 
 As the p value for the given data is lesser(p<0.05) than 0.05 ,it is 
significant. Thus, sepsis in hypoglycaemic patient is a significant 
predictor of mortality. 
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Mortality Pattern Based on Age Group 
 
 
 
Maximum number of people in the study were in the category of 
41-60 years. This category accounted to 54.62% of the sample. Next in 
order of frequency was 61-80 years category. There were 41 patients 
(34.45%) in this age group. However, maximum number of deaths belong 
to this category of patients. 
Chi square statistical analysis was done on the age group data of 
the sample to know if increasing age was an important predictor of 
mortality in hypoglycaemic patient. 
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Chi Square Table for Age Group as a predictor of Mortality 
 
Age Mortality No Mortality Total 
0-20 0 (0%) 2 (2.2%) 2 (1.7%) 
21-40 3 (11.5%) 8 (8.6%) 11 (9.2%) 
41-60 7 (26.9%) 58 (62.4%) 65 (54.6%) 
61-80 16 (61.5%) 25 (26.9%) 41 (34.5) 
Total 26 (100%) 93 (100%) 119 (100%) 
 
 
p value significance level   0.05 
 Chi Square Value       : 9.3063 
 P value          : 0.0022 
 
 As the p value for the given data is lesser(p<0.05) than 0.05 ,it is 
significant. Thus, sepsis in hypoglycaemic patient is a significant 
predictor of mortality. 
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Mortality Pattern Based on Number of Risk Factors 
 
 
 
  
As we analyse the presence of risk factors in hospitalized 
hypoglycaemic patents, it was found that as the number of risk factors in 
a patient increases, chance of succumbing to them also increases. Number 
of deaths which occur when there was one risk factor was 4 out of 26 
which works out to 15.38%. In the category of patients having 3 or more 
risk factors death rate was 15 out of 42 which is 35.71%. 
Chi square test analysis was done on the data of number of risk 
factors to know if the number of risk factors could be a predictor of 
mortality. 
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Chi Square Table for Number of risk Factors as a predictor of 
Mortality 
 
p value significance level   0.05 
Chi Square Value  : 7.3361 
P value   : 0.0255 
 
 As the p value for the given data is lesser(p<0.05) than 0.05 ,it is 
significant. Thus, presence of increase number of risk factors in 
hypoglycaemic patient is a significant predictor of mortality.              
  
Number of Risk 
Factors 
Mortality No Mortality Total 
1 4 22 26 
2 7 44 51 
3 or More 15 27 42 
Total 26 93 119 
  
 
 
DISCUSSION 
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DISCUSSION 
 In our study conducted in the medical wards of madras medical 
college hospital around 119 patients were found to have at least one 
episode of hypoglycemia in 6 month study period. The incidence is found 
to be 1.05%. This includes in both diabetic and non diabetic patients. 
Alexander turchin etal(78) have shown an incidence of 7.7% in patients 
with diabetes. The lower incidence in our study is probably due to 
considering hypoglycemia incidence in both diabetic and non diabetic 
population. More over incidence was calculated for the entire admissions 
to the medical wards in the entire 6 month period that includes 11276 
admissions. 
 
 In our study maximum number of patients was in the age group of 
41-60 yrs accounting for 54.6% followed by >60 yrs age group 
accounting for 34.5%. However this age group of >60 yrs constituted 
61.5% of total deaths. Hypoglycemia in elderly age group is a significant 
predictor of mortality. 
 
 The commonest risk factors associated with low blood sugar levels 
in our study are Renal failure (57.98%) , Diabetes on therapy (56.3%) and 
alcoholism (49.57%). 
87 
 
 
 
 Within the category of Diabetes Mellitus patients  association with 
renal failure was the commonest cause of hypoglycaemia. 
 
 In our study diabetes and chronic kidney disease are the major risk 
factors for hypoglycemia. This is in accordance with Kathleen.F . Fischer 
et al(79) in whose study diabetes was present in 45% of patients with 
hypoglycemia and CKD was the next most common cause of 
hypoglycemia in non diabetic patients. 
 
 The present study highglights the fact that low blood sugar levels 
can also occur in non diabetic patients. 
 
 In diabetic patients also renal failure forms the major risk factor for 
hypoglycemia. This is in accordance to S.G.Bruderer et al(80) in whose 
study risk factors for severe hypoglycemia were insulin treatment , renal 
failure and increasing age. 
 
 In Non-diabetic patients renal failure and sepsis form common 
causes of hypoglycaemia.  
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 Though CKD and diabetes are the major risk factors for 
hypoglycemia they are not significant predictors of mortality.   
 
 In our study hypoglycemia is also seen in congestive cardiac 
failure. This is in accordance with several previous studies. Benzing G. 
Scheubert et al(23), Heydati et al(24)  and Block M.B et al(81) have shown 
spontaneous hypoglycemia in CCF.  
 
 Hypoglycemia is also common in elderly. This is in accordance 
with Shilo.S.et al(82) study. In our study hypoglycemia in sepsis and CCF 
significantly predicts mortality. Similarly, we found that hypoglycemia in 
old age is also a significant predictor of mortality. The present study also 
shows that more the number of risk factors the greater chance of 
mortality.  In our study , significant predictors of mortality in hospitalised 
hypoglycaemic patients are associations with 1.sepsis 2.CCF 3.elderly 
age 4. Presence of multiple risk factors. 
 
 Alcohol intoxication and alcoholic hepatitis are also major risk 
factors of hypoglycemia in our study. This is in accordance to Heather 
Hammerstedt et al(83) who have demonstrated hypoglycemia in alcohol 
intoxication. Though western studies have shown less incidence of 
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alcohol induced hypoglycemia , in our study acute alcohol intoxication 
accounts for 2.52% and alcoholic hepatitis accounts for 8.4% in our 
study. Next to diabetes and CKD alcohol also forms a major risk factor 
for hypoglycemia.  This may be due to higher prevalence of significant 
alcohol in this part of the country. The higher incidence of hypoglycemia 
in males in our study may be alcohol related. 
 
 Thus, to conclude predisposing factors for hypoglycemia in 
hospitalised patients in present study are diabetes on treatment, CKD, 
alcohol dependence, sepsis, CCF and elderly. These risk factors are in 
accordance with previous studies. 
 
 
 
 
 
 
 
 
 
 
  
 
 
CONCLUSION 
  
90 
 
 
 
 
CONCLUSION 
 
 Hypoglycaemia reveals dysregulation in glucose metabolism in 
the body and failure of endogenous defense mechanisms to 
combat low blood sugar levels. 
 
 Hypoglycaemia should always be taken seriously and 
investigated properly.  
 
 Apparently hypoglycaemia is common in diabetes but it is clear 
from this study that even in diabetes serious disease process like 
renal dysfunction, cardiac failure or sepsis precipitates 
hypoglycaemia. 
 
 In Non-diabetic patients renal failure, sepsis and alcoholic 
hepatitis are the common causes of hypoglycaemia. 
 
 In a T2DM patients without organ failure, the low blood sugars 
experienced due to OHA/Insulin food mismatch is only mild. 
 
 Alcohol is another most important factor for causing 
hypoglycaemia in our country. 
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 In our study of 119 patients, we did not find Insulinoma as a 
cause of  hypoglycaemia. Insulinoma is very rare and it is  
prudent to think of common causes like alcoholism and CKD 
apart from diabetes as main causes of hypoglycaemia. 
 
 Though mild hypoglcemia is reversible with oral or IV glucose, 
profound and prolonged hypoglycaemia can cause 
encephalopathy and prove fatal. 
 
 In patients with sepsis and congestive cardiac failure 
hypoglycaemia is a predictor of mortality. 
 
 Similarly as the number of risk factors increase, the mortality 
rate also increases. Perhaps here multiple risk factors play a 
role. 
 
 Elderly people are more prone for low blood sugar levels. In 
them Diabetes treatment should be moderate. Tight glycemic 
control in the elderly can lead to fatal episodes of 
hypoglycaemia. 
 
 It is better to prevent hypoglycaemia in diabetes. However   it is 
prudent to investigate any patient presenting with 
hypoglycaemia. 
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ANNEXURES 
  
ABBREVIATIONS 
 
1. OHA   - Oral hypoglycemic agents 
2.CNS   - Central nervous system 
3. HMP   - Hexose monophosphate shunt 
4.GLUT   - glucose transporters 
5.ECF  -  Extracellular fluid 
6.PPRγ   -  Peroxisome proliferator activated receptor 
7.PCP   -  Pneumocystis carinii pneumonia 
8.ACE   - Angiotensin converting enzyme 
9.NEFA   - Non esterified fatty acids 
10. T1DM  - Type 1 Diabetes mellitus 
11.T2DM  - Type 2 Diabetes mellitus 
13.DM  - Diabetes mellitus 
14.NAD   - Nicotinamide Adenine Dinucleotide coenzyme 
15. NADH  -  Nicotinamide Adenine Dinucleotide hydride 
16.ICU   -  Intensive care unit 
17.RHD   -  Rheumatic Heart disease 
18. COPD   -  Chronic obstructive pulmonary disease 
19.GIT   -  Gastro intestinal tract 
20.HAAF   - Hypoglycemia associated autonomic failure 
21.MRI   - Magnetic resonance imaging 
22.QTc   - Corrected QT interval 
23. IL-8   -  Interleukin 8 
24.IL-6   -  Interleukin 6 
25.CRP   -  C-Reactive protein 
26.TNF α   - Tumour necrosis factor α 
27.SC   - Subcutaneous 
28.IM   -  Intramuscular 
29.CCF   - Congestive cardiac failure 
30.i.e    -  that is 
31.RHD   - Rheumatic Heart disease 
32.CAD   - Coronary Heart disease 
33.CKD   - Chronic kidney disease 
34.DCLD   -  Decompensated liver disease 
35.ESR   -  Erythrocyte sedimentation rate 
36.CT scan  - Computed tomography scan 
 
 
PROFORMA 
PROFILE OF HOSPITALISED PATIENTS WITH EPISODES OF 
HYPOGLYCEMIA 
Name:  Age:   Sex:   IP Number: 
Presenting Complaints: 
H/O Present Illness      : 
 
 
Past History                  : 
 Diabetes                       : 
Hypertension                : 
CAD / DCM                 : 
RHD                             : 
Cirrhosis                       : 
CKD                             : 
Others                           : 
 
Personal History           : 
Alcohol                         : 
Smoking                       : 
Others                           : 
 
Occupational  History  : 
Nutritional Pattern        : 
Drug Intake                   : 
 
O/E :  
PR : 
BP: 
RR: 
Temp : 
CBG (at time of admission ) : 
General examination : 
 
 
CVS : 
 
RS : 
 
ABDOMEN : 
 
CNS : 
  
 
Investigations: 
1. Complete Blood Count: 
Hb:   TC:   DC: P L E M 
ESR:   PCV:   Platelet: 
2. Renal Function Tests: 
S. Urea:   S.Creatinine:   
S. Na:   S. K: 
3. FBS: 
4. PPBS 
5.RBS 
6.Liver Function Tests : 
Total Bilirubin 
SGOT 
SGPT 
GGT 
Alkaline phosphatise 
Sr.Total protein : 
Sr.Albumin : 
7. Thyroid Function Tests: 
 
8.ECG : 
9. USG : 
10.ECHO:                                                11. Others (if any): 
  
INFORMATION SHEET 
 
We are conducting a study on “CLINICAL PROFILE OF 
HOSPITALISED PATIENTS WITH EPISODE OF HYPOGLYCEMIA’’ 
among patients in Rajiv Gandhi Government General Hospital, Chennai and 
for that your specimen may be valuable to us. 
 
 The purpose of this study is to identify the incidence, clinical pattern, 
associated risk factors and mortality rate among hospitalised patients with 
hypoglycaemic episodes. We are selecting certain cases, and if you are eligible, 
2 samples of 3 cc blood will be collected in fasting state in the morning and 
sent for investigations. These tests do not affect your final report or 
management. 
 
The privacy of the patients in the research will be maintained throughout 
the study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 
The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may aid 
in the management or treatment 
 
Signature of the Investigator   Signature of the Participant 
 
Date: 
Place: 
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ேததி: 
PATIENT CONSENT FORM 
Study Title : PROFILE OF HOSPITALISED PATIENTS 
WITH EPISODE OF HYPOGLYCEMIA 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Name :  
Age/Sex :  
Identification 
Number 
:  
Patient may check (☑) these boxes 
The details of the study have been provided to me in writing and 
explained to me in my own language ❏ 
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal 
rights being affected. ❏ 
I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be 
conducted in relation to it, even if I withdraw from the study I agree to 
this access. However, I understand that my identity will not be 
revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any 
data or results that arise from this study. ❏ 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team 
and to immediately inform the study staff if I suffer from any 
deterioration in my health or well being or any unexpected or unusual 
symptoms. ❏ 
I hereby consent to participate in this study. ❏ 
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological and biochemical tests. ❏ 
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Patient’s Name and Address:   Study Investigator’s Name: 
Dr. R.VASUKI 
ஆராசி ஒ,6த க8த3 
ஆராசி தைல,6: 
தாநிைல ச"#கைர காரணமாக மவமைனய 
அ+மதிக,ப-ட ேநாயாள0கள0  மவ வவர1க ப$றிய 
ஆராசி. 
 
ெபய": ேததி: 
வய: உேநாயாள0 எB: 
பா: ஆராசி ேச"#ைக எB: 
இத ஆராசிய வவர1க53 அத ேநா#க1க53 
7Cைமயாக என#2 ெதள0வாக வள#க,ப-ட. என#2 வள#க,ப-ட 
வஷய1கைள நா 6= ெகாB: நா என ச3மதைத 
ெத=வ#கிேற. 
இத$காக ேம$ெகாள ேவB8ய இரதப=ேசாதைன ம$(3 
>ேக ப=ேசாதைன ப$றி<3 வள#கெப$( நா ஆராசிய 
ப1ேக$கிேற. 
ேம$ெகாBட ப=ேசாதைனய ேபா ஏ$பட#F8ய 
பவைள9கைள<3 7Cவ3 உண" இத ப=ேசாதைன#2 
மனமார ச3மதி#கிேற. 
 
ஆராசியாள" ைகெயா,ப3                ப1ேக$பாள" ைகெயா,ப3 
 
ேததி: 
  
  
 
 
 
 
MASTER CHART 
 
VI
R
A
L
A
L
C
H
O
H
O
L
T
O
X
I
C
C
A
D
R
H
D
D
C
M
L
I
V
E
R
O
T
H
E
R
S
O
H
A
I
N
S
U
L
I
N
M
O
R
T
A
L
I
T
Y
1 40653 68 M 62 6.8 N Y Y Y N N N N N N Y N N N N N N N Y
2 46785 66 M 69 6.5 N N Y N N N N N N N N N N N N N N N N
3 67584 70 M 45 7 N N Y N N N N N N N Y N N N N N N N Y
4 56784 69 M 68 5.8 N N Y N N N N N N N N N N N N N N N N
5 56784 71 M 45 7.4 N N Y N N N N N N N Y N N N N N N N Y
6 56743 74 M 57 6.4 N N Y N N N N N N N N N N N N N N N N
7 58765 76 M 66 6.5 N N Y N N N N N N N Y N N N N N N N Y
8 56784 77 M 65 6 N Y Y N N N N N N N N N N N N N N N N
9 52876 74 F 45 7.5 Y N Y N N N N N N N Y N N N N N N N Y
10 56784 69 F 56 5.6 N N Y N N N N N N N N N N N N N N N N
11 56432 75 F 45 5.8 Y N Y N N N N N N N Y N N N N N N N Y
12 56473 77 M 46 6.7 N N Y N N N N N N N N N N N N N N N N
13 47658 71 M 64 5.7 N N Y N N N N N N N N N N N N N N N N
14 49876 28 F 56 5.5 N N N N N N Y N N N N N N N N N N N Y
15 42768 31 M 45 6.7 N Y N N N Y N N N N N N N N N N N N Y
16 56721 37 M 56 4.5 N Y N N N N N N N N N N Y N N N N N Y
17 56487 68 M 67 6.8 N N Y N N N N N N N N N N N N N N N N
18 55674 74 M 56 6.7 N Y Y N N N N N N N N N N N N N N N N
19 55342 71 M 45 7 N Y Y N N N N N N N N N N N N N N N N
20 55876 79 M 46 5.7 N Y Y N N N N N N N N N N N N N N N N
21 53452 72 M 67 5.8 N Y Y N N N N N N N N N N N N N N N N
22 57896 68 M 45 6 N N Y N N N N N N N N N N N N N N N N
23 53897 48 M 34 7.8 Y Y Y Y N N N N N N N N N N N N N N N
24 56786 58 M 56 8.6 N Y Y Y N N N N N N N N N N N N N N N
25 56784 44 F 56 6.8 N N N N N N N N N N Y N N N N N N N N
26 47896 51 F 45 7.8 Y N N N N N N N N N Y N N N N N N N N
27 46537 50 F 45 6.5 Y N N N N N N N N N Y N N N N N N N N
28 57863 49 F 56 7.9 Y N N N N N N N N N Y N N N N N N N N
29 49399 43 M 56 8 N Y N N N N N N N Y N N N N N N N N Y
30 50221 44 M 67 7.5 N Y N N N N N N N Y N N N N N N N N Y
31 50477 42 M 66 7.5 N N N N N N N N Y N N N N N N N N N Y
32 50789 71 M 66 5.6 Y N N N N N N N N Y N N N N N N N N Y
33 50967 69 M 45 6.7 Y Y N N N N N N N Y N N N N N N N N Y
34 51124 70 M 54 6.6 Y Y N N N N N N N Y N N N N N N N N Y
35 51231 68 M 54 5.8 N N Y N N N N N N N N N N N N N N N N
36 51179 77 M 45 5.9 N Y Y N N N N N N N N N N N N N N N N
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37 52343 74 M 42 7.6 N Y Y N N N N N N N N N N N N N N N N
38 53234 70 M 56 5.8 N N Y N N N N N N N N N N N N N N N N
39 53222 47 M 56 6.9 Y Y Y N N N N N N N N N N N N N N N N
40 53127 49 F 55 7.9 Y N Y N N N N N N N N N N N N N N N N
41 52179 57 M 56 6.9 Y N Y N N N N N N N N N N N N N N N N
42 52774 51 F 54 7.6 Y N Y N N N N N N N N N N N N N N N N
43 52144 54 M 67 5.8 Y Y Y N N N N N N N N N N N N N N N N
44 52411 53 M 56 6.8 Y Y Y N N N N N N N N N N N N N N N N
45 52737 56 F 56 7.8 Y N Y N N N N N N N N N N N N N N N Y
46 52999 51 M 56 5.9 Y N Y N N N N N N N N N N N N N N N Y
47 53044 59 F 56 7 Y N Y N N N N N N N N N N N N N N N Y
48 53087 54 M 67 6.5 Y Y Y N N N N N N N N N N N N N N N Y
49 53094 66 F 65 6.6 Y Y Y N N N N N N N N N N N N N N N N
50 53123 77 M 55 6 Y Y Y N N N N N N N N N N N N N N N N
51 53717 51 F 44 6.8 Y N Y N N N N N N N N N N N N N N N N
52 53786 54 F 45 6.9 Y N Y N N N N N N N N N N N N N N N N
53 53799 49 F 45 7 Y N Y N N N N N N N N N N N N N N N N
54 53914 47 M 45 6 N N N Y N N N N N N N N N N N N N N N
55 53977 29 F 45 7 N NN N N Y N N N N N N N N N N N N N N
56 53988 37 M 57 6.8 N Y N N N Y N N N N N N N N N N N N N
57 53993 31 M 56 6.9 N Y N N N Y N N N N N N N N N N N N N
58 53967 57 M 56 6.8 Y N Y N N N N N N N N N N N N N N N N
59 54110 47 M 56 6.5 Y Y Y N N N N N N N N N N N N N N N N
60 53211 51 M 65 7 Y N Y N N N N N N N N N N N N N N N N
61 53216 49 M 56 7.5 Y Y Y N N N N N N N N N N N N N N N N
62 54719 56 M 57 5.9 Y Y Y N N N N N N N N N N N N N N N N
63 54747 69 M 68 6.9 Y Y Y N N N N N N N N N N N N N N N Y
64 54788 70 F 56 7 Y N Y N N N N N N N N N N N N N N N Y
65 54792 76 M 55 7.5 Y N Y N N N N N N N N N N N N N N N Y
66 54800 78 F 54 6.8 Y N Y N N N N N N N N N N N N N N N Y
67 54804 74 M 41 6.9 Y Y Y N N N N N N N N N N N N N N N N
68 54807 73 F 45 5.6 Y N Y N N N N N N N N N N N N N N N N
69 54813 69 F 48 6.6 Y N Y N N N N N N N N N N N N N N N N
70 54834 78 M 42 5.9 Y Y Y N N N N N N N N N N N N N N N N
71 54867 49 M 56 6.5 N Y N N N Y N N N N N N N N N N N N N
72 54888 57 M 57 6.9 N Y N N N Y N N N N N N N N N N N N N
73 54991 51 M 54 7 N Y N N N Y N N N N N N N N N N N N N
74 54997 76 M 39 6.5 Y Y Y N N N N N N N N N N N N N N N Y
75 54998 71 M 35 7.5 Y Y Y N N N N N N N N N N N N N N N Y
76 55110 54 M 54 5.9 N Y N N N Y N N N N N N N N N N N N N
77 55117 39 M 34 7.6 Y Y N N N Y N N N N N N N N N N N N N
78 55222 34 M 45 5.6 Y Y N N N Y N N N N N N N N N N N N N
79 55234 37 M 56 6.8 Y Y N N N Y N N N N N N N N N N N N N
80 55267 34 M 46 6.8 N Y N N N Y N N N N N N N N N N N N N
81 55319 51 M 67 6 N Y N N N Y N N N N N N N N N N N N N
82 55198 80 M 54 7.8 N N N N N N N N N N N N N Y N N N N N
83 55190 49 F 68 6.8 Y N Y N N N N N N N N N N N N N N N N
84 55343 57 M 67 5.9 Y Y Y N N N N N N N N N N N N N N N N
85 47895 56 F 66 6.8 Y N Y N N N N N N N N N N N N N N N N
86 43687 51 M 68 6.5 Y N Y N N N N N N N N N N N N N N N N
87 44786 54 F 68 6 Y N Y N N N N N N N N N N N N N N N N
88 45891 49 M 66 5.6 N Y N N N N N N N N N N N N N N N N N
89 51423 57 M 68 7.8 N Y N N N Y N N N N N N N N N N N N N
90 51347 58 M 68 6.8 N Y N N N Y N N N N N N N N N N N N N
91 52673 69 M 67 7 N N N N N Y N N N N N N N N Y N N N N
92 52874 71 M 54 6.5 N N N N N N N N N N N N N N Y N N N N
93 52789 32 M 54 6.8 N Y N N N N N N N N N N Y N N N N N N
94 53784 51 M 55 7.9 N Y N N N N N N N N N N Y N N N N N N
95 51908 57 M 55 6.9 Y Y Y N N N N N N N N N N N N N N N N
96 54896 50 M 56 5.7 Y Y Y N N N N N N N N N N N N N N N N
97 54872 59 M 68 6.9 Y Y Y N N N N N N N N N N N N N N N N
98 54908 54 M 54 5.8 Y Y Y N N N N N N N N N N N N N N N N
99 56743 51 M 58 6.8 Y N Y N N N N N N N N N N N N N N N N
100 55478 58 M 56 6.9 Y Y N N N N N N N N N Y N N N N N N N
101 55453 56 M 56 6.8 Y Y N N N N N N N N N Y N N N N N N N
102 55674 59 M 47 6.9 Y Y N N N N N N N N N Y N N N N N N N
103 57812 51 M 54 6.7 Y N Y N N N N N N N N N N N N N N N N
104 57621 54 M 47 6.9 Y Y Y N N N N N N N N N N N N N N N N
105 49764 53 M 48 5.9 Y Y Y N N N N N N N N N N N N N N N N
106 42903 58 M 56 6.9 Y Y Y N N N N N N N N N N N N N N N N
107 42563 57 M 58 6.6 Y N Y N N N N N N N N N N N N N N N N
108 46752 19 F 67 6.8 Y N N N N N N N N N N N N N N N Y N N
109 47586 19 F 65 5.9 Y N N N N N N N N N N N N N N N Y N N
110 41433 54 F 54 5.5 Y N N N N N N N N N N N N N N N Y N N
111 478592 47 F 78 6 Y N N N N N N N N N N N N N N Y N N N
112 47652 49 F 65 5.9 Y N N N N N N N N N N N N N N Y N N N
113 43675 46 M 54 6 Y Y N N N N N N N Y N N N N N N N N N
114 45987 51 M 44 7 Y N N N N N N Y N N N N N N N N N N N
115 51367 58 M 44 6.5 N N N N N N N N Y N N N N N N N N N N
116 47652 54 M 56 5.9 N N N N N N N N Y N N N N N N N N N N
117 47659 53 M 57 6.7 N N N N N N N Y N N N N N N N N N N N
118 53622 51 M 54 6.5 N N N N N N N N N N N N N N N N N Y N
119 53711 56 M 55 6 Y Y N N N N N N N N N N N N N N N N N
  
 
 
 
 
 
  
 
